4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-021643
Chief Financial Officer bought 4,500 shares at $8.56 ($38,520)
From the SEC's structured data for this filing
Trades in this filing
WEAVER GREGORY L · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-23 | Purchase : show line 1 in the form | +4,500 | $8.56 | $38,520 | 4,500 | D |
| Open-market purchases · 4,500 sh · avg $8.56 · $38,520 | ||||||
Loading xslF345X03/doc4.xml…